Information  X 
Enter a valid email address

Maven Inc&Grwth 5 (MIG5)

  Print      Mail a friend

Tuesday 04 May, 2021

Maven Inc&Grwth 5

Statement re Dividend Investment Scheme

RNS Number : 5163X
Maven Income and Growth VCT 5 PLC
04 May 2021

Maven Income and Growth VCT 5 PLC


Net Asset Value (NAV) - Dividend Investment Scheme (DIS)


The Board of Maven Income and Growth VCT 5 PLC (the Company) has announced previously that the NAV per share of the Company as at 28 February 2021 was 38.47 p and that a final dividend of 1.10 p per share in respect of the year ended 30 November 2020 would be paid on 7 May 2021 , to Shareholders on the register at close of business on 9 April 2021 . Furthermore, in respect of Shareholders who had, by no later than 23 April 2021 , elected to participate in the DIS, the Company will use the amount paid in respect of the above final dividend to subscribe for new ordinary shares of 10p each in the Company (Ordinary Shares) to be issued at a price equivalent to the latest announced NAV per share.


The Board confirms that, following the payment of the above dividend, the effective NAV per share of the Company is 37.37p and that this will be the price used in the calculation of the number of Ordinary Shares to be allotted under the DIS in respect of the final dividend, the issue of which will be confirmed in a separate announcement in due course.


Issued on behalf of the Board


Maven Capital Partners UK LLP


4 May 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t